secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K
Filed at:   2023-12-11T23:59:59+00:00
Accession:  0001558370-23-019713
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Coherus CFO Stilwell resigns; EVP McMichael named Interim CFO
-------------------------------------------------------------

- McDavid Stilwell resigned as CFO and Principal Financial Officer, effective Dec 31, 2023, to pursue other opportunities.
- Bryan McMichael appointed Interim CFO and Principal Financial Officer, effective Dec 8, 2023.
- McMichael continues as EVP, Accounting, Corporate Controller and Principal Accounting Officer; previously at Gilead Sciences.
- No compensatory changes or grants in connection with the interim appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000155837023019713/0001558370-23-019713-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000155837023019713/chrs-20231209x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-019713

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer